1
Clinical Trials associated with Adalimumab Biosimilar(Laboratorios Richmond)A Randomized, Double-blind, Parallel Groups, Phase 1 Clinical Study Comparing the Pharmacokinetic, Safety and Immunogenicity of Adalimumab in Healthy Subjects
The study aims to evaluate the pharmacokinetic profile, safety profile, and immunogenic potential of adalimumab of a new citrate-free formulation of adalimumab (Adalimumab Richmond) [Test Product] vs. Humira® AC Pen [Reference Product]
100 Clinical Results associated with Adalimumab Biosimilar(Laboratorios Richmond)
100 Translational Medicine associated with Adalimumab Biosimilar(Laboratorios Richmond)
100 Patents (Medical) associated with Adalimumab Biosimilar(Laboratorios Richmond)
100 Deals associated with Adalimumab Biosimilar(Laboratorios Richmond)